Member login

Forgot Password?

By using the members area you have already agreed to share your personal information with the BBA so that you can access the members materials. We will store your details only as long as you are a member. Your personal information will not be shared any affiliated companies or third parties. For more information about our Privacy Policy, click here.

Return to login
Better access to high quality biological medicines
The British Biosimilars Association (BBA) is the expert sector group of the British Generic Manufacturers Association (BGMA) exclusively focused on biosimilars

The British Biosimilars Association (BBA) is the expert sector group of the British Generic Manufacturers Association (BGMA) exclusively focused on biosimilars.

The members of the BBA ensure access to high quality, safe and effective biosimilar medicines for UK patients. As industry experts, we partner with patients’ representatives, healthcare professionals, regulators and payers to increase understanding and to drive a sustainable environment for the development, production and continuing optimised use of biosimilar medicines across the UK.

For more information about Biosimilars, please take a look at NHS England’s ‘What is a Biosimilar’ document.

Twitter

17.08.2018
RT @DawnConnelly73: With blockbuster #biologic #adalimumab coming off patent in October 2018, #Pharmacists should be ready to switch patients to the best-value biologic as alternatives become available #biosimilars @keithridge1 @robinson_julia @NRAS_UK @BritBiosimilars https://t.co/NCwJLg18Sr
17.08.2018
RT @PJOnline_News: With blockbuster #biologic #adalimumab coming off patent in October 2018, #Pharmacists should be ready to switch patients to the best-value biologic as alternatives become available #biosimilars @keithridge1 @robinson_julia @NRAS_UK @BritBiosimilars https://t.co/OSnAY5hS3u
17.08.2018
RT @PharmaMgrsInst: We delighted to announce that Kavya Gopal Head Specialty Business with @Sandoz_Global UK and Chair of @BritBiosimilars will be speaking at our #NationalBiosimilarsForum on October 25th Full details here: https://t.co/4QkQldco9i #biosimilars #ThePMI18 #biosimilarsforum
09.08.2018
RT @PJOnline_News: Proposals to include biologics in price controls could threaten NHS savings, says biosimilars head #pharmacy https://t.co/Lfwx5LRxCw
09.08.2018
RT @Britishgenerics: https://t.co/Tc27ZN1t8W